<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">

Cell-based Assays


Speak with a scientist

MD Biosciences performs high throughput and medium throughput cell based assays using neural tissues derived from animals, iPS-derived stem cells, neuronal cells, cardiomyocytes, PBMCs, and neural micro-tissues that closely mimic the human brain.

There are many advantages to cell based assays, which are now gaining regulatory acceptance as part of the preclinical package for drug development. Cell based assays are cost and time effective, and are an advantageous model for high throughput screening, safety and efficacy. The results are highly reproducible and relevant to the clinic, especially when derived from human cells. All of our assays provide valuable insights on mode of action and can be used to evaluate therapeutics for diseases that are difficult to model in animals, like Alzheimer's.

Cell-based Assays:



If you are ready to discuss how a partnership can fit into your development program, our scientists are eager to explore the possibilities with you. Like many other pharmaceutical and medical device developers, you can rely on predictive preclinical data.

Request Proposal